Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra QIXLEEF

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Oct 25, 2021 10:07pm

85 Views

Post# 34048060

RE:RE:RE:RE:Tetra QIXLEEF

Dave, do you see the interest in the stock. How many bashers are hanging around and very active for the past few months ahead of major milestones here. Plus the very strong fundamentals. It has the most advanced trials against opioid in North America. Most of cannabis based drugs failed in phase i due to safety. Tbp already passed that and phase ii so far so good. Now last nr they want to market this based on phase ii. All these tell a story. If there is no value you won't see all these clowns around this cake.

<< Previous

Bullboard Posts

Next >>

A&W will expand Pret A Manger brand across Canada